🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Both Chinese & external expert groups are trying to identify the animal source of 2019-nCoV. Identifying it would help to ensure that there will be no further similar outbreaks & will also help to understand the initial spread of #COVID19 in the Wuhan area, 🇨🇳

We convened experts & R&D funders at World Health Organization (WHO) to set priorities for stopping the #COVID19 outbreak, incl: -how to apply diagnostics -the best approaches for infection prevention -potential therapies that could be used now -existing vaccine candidates -how to address the infodemic

Research is an integral part of the outbreak response; I appreciate the positive response from the research community for joining us at short notice and coming up with concrete plans and commitments to work together to end the #COVID19 outbreak. bit.ly/38nM0YL

To fight a common enemy that does not respect borders, such as #COVID19, we need to: 1⃣ work together 2⃣ ensure that we have all necessary resources 3⃣ bring our best science to the forefront to find shared answers to shared problems. bit.ly/38nM0YL

Daily press conference on #COVID19 with Mike Ryan. #coronavirus pscp.tv/w/cRVkqTI2MTAy…

I'm really grateful to all the laboratory #healthworkers around the world, including those in 🇰🇭 in this photo, who are conducting #COVID19 tests with such great care. Their expertise & humanity are fundamental to stop #coronavirus from spreading further. 📷: Institut Pasteur du Cambodge

Look forward to joining President Felix Tshisekedi, Présidence RDC 🇨🇩 at the launch of #DRC 🇨🇩‘s National #UHC Strategy tomorrow. In my absence, Mike Ryan briefed media on the #coronavirus response.

Tedros Adhanom Ghebreyesus "The transition from #Ebola to universal health coverage provides a unique opportunity to strengthen the entire #DRC health system, as long as the political commitment translates into the adequate & progressive mobilization of domestic resources"-Tedros Adhanom Ghebreyesus

#COVID19 issues. 3) Since SARS fundamental postive reforms in China and World Health Organization (WHO) - the China Centre Disease Control professionalised, clinical care within China, Health Emergencies Programme World Health Organization (WHO), Tedros Adhanom Ghebreyesus personal leadership, Mike Ryan Soumya Swaminathan WHO R&D Blueprint & team

The potential spread of the #coronavirus to countries with weaker health systems is one of our biggest concerns. World Health Organization (WHO) thanks CERF - The UN's emergency fund for releasing $15 million to help these countries battle the spread of the virus. bit.ly/2IbEWDo

Our message to all countries is: this is not one-way street. We can push this #coronavirus back. Your actions now will determine the course of the #COVID19 outbreak in your country. There’s no choice but to act now.

An emotional day in #Beni #DRC as Masiko, the last #Ebola patient in DRC leaves the Ebola treatment centre in #Beni! Our World Health Organization (WHO) team was delighted to share this victory with Masiko, Ministère de la Santé RDC, our partners, & the people of Beni.

who.int/blueprint/prio… 4-pager distilling ethical guidance on COVID-19 research. Great work from ethics group formed out of WHO R&D Blueprint COVID-19 research forum WHO R&D Blueprint World Health Organization (WHO)

World Health Organization (WHO) Tedros Adhanom Ghebreyesus SOLIDARITY trial provides simplified procedures so even overloaded hospitals can participate. Argentina, Bahrain, Canada, France, Iran, Norway, South Africa, Spain, Switzerland and Thailand already confirmed to participate.

There are now 508 COVID-19 trials listed on WHO ICTRP apps.who.int/trialsearch/Ad…

World Health Organization (WHO) Tedros Adhanom Ghebreyesus Mike Ryan Maria Van Kerkhove Details on SOLIDARITY trial for #covid19 treatment: adaptive design, countries can choose, drugs can be added, but starting with 5 arms. - standard of care - remdesivir - lopinavir and ritonavir - lopinavir, ritonavir and interferon-beta - chloroquine

It seems China's clinical trials may not have generated enough data to tell the world if repurposed drugs work against #Covid19. World Health Organization (WHO) has launched a multi-arm, multi-country trial to fill this critical knowledge gap. statnews.com/2020/03/18/who…

The #Solidarity trial harnesses global cooperation in research to answer important public health questions related to #COVID19. World Health Organization (WHO) WHO R&D Blueprint created to undertake ethical research during emergencies Tedros Adhanom Ghebreyesus Canada's CPHO John-Arne Røttingen Jeremy Farrar Trevor Mundel @JEPaquetEU

Number of COVID-19 #clinicaltrials in the #ICTRP database who.int/ictrp World Health Organization (WHO) Soumya Swaminathan

In the phase 3 mRNA-1273 trial participants received 2 doses of vaccine or placebo 28 days apart. The mRNA-1273 vaccine showed 94.1% efficacy in preventing #SARSCoV2, including severe disease. #IDTwitter